0000939767-17-000151.txt : 20170915
0000939767-17-000151.hdr.sgml : 20170915
20170915184336
ACCESSION NUMBER: 0000939767-17-000151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170914
FILED AS OF DATE: 20170915
DATE AS OF CHANGE: 20170915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haley Patrick J.
CENTRAL INDEX KEY: 0001692954
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 171088789
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_150551540227057.xml
FORM 4
X0306
4
2017-09-14
0
0000939767
EXELIXIS, INC.
EXEL
0001692954
Haley Patrick J.
210 EAST GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Sr. Vice President, Commercial
Common Stock
2017-09-14
4
S
0
60640
27.21
D
41553
D
Common Stock
23539
I
By spouse
Common Stock
9954
I
By 401(k)
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.19 to $27.25. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
Includes 27,553 shares of Exelixis, Inc common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 2,361 shares of common stock acquired pursuant to the Exelixis , Inc. 2000 Employee Stock Purchase Plan on April 28, 2017.
Represents 9,954 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 13, 2017.
/s/ Jeffrey J. Hessekiel, Attorney in Fact
2017-09-15